Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Clearside Biomedi (CLSD)

Clearside Biomedi (CLSD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Clearside Biomedical, Inc. (CLSD) Reports Q1 Loss, Misses Revenue Estimates Zacks - Thu May 11, 2023

Clearside Biomedical, Inc. (CLSD) delivered earnings and revenue surprises of -7.14% and 98.44%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?...

CLSD : 1.2900 (-3.73%)
AFMD : 5.49 (+9.15%)
TScan Therapeutics, Inc. (TCRX) Reports Q1 Loss, Tops Revenue Estimates Zacks - Wed May 10, 2023

TScan Therapeutics, Inc. (TCRX) delivered earnings and revenue surprises of -27.40% and 119.52%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?...

TCRX : 7.68 (+4.92%)
CLSD : 1.2900 (-3.73%)
Prometheus Biosciences, Inc. (RXDX) Reports Q1 Loss, Tops Revenue Estimates Zacks - Tue May 9, 2023

Prometheus Biosciences, Inc. (RXDX) delivered earnings and revenue surprises of 6.52% and 74.57%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?...

RXDX : 199.92 (+0.09%)
CLSD : 1.2900 (-3.73%)
Alector (ALEC) Reports Q1 Loss, Tops Revenue Estimates Zacks - Thu May 4, 2023

Alector (ALEC) delivered earnings and revenue surprises of 26.67% and 79.32%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

ALEC : 5.26 (+0.19%)
CLSD : 1.2900 (-3.73%)
Clearside Biomedical, Inc. (CLSD) Reports Q4 Loss, Tops Revenue Estimates Zacks - Thu Mar 9, 2023

Clearside Biomedical, Inc. (CLSD) delivered earnings and revenue surprises of -23.08% and 111.54%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the...

CLSD : 1.2900 (-3.73%)
AEZS : 1.9500 (-0.32%)
Regenxbio (RGNX) Reports Q4 Loss, Lags Revenue Estimates Zacks - Tue Feb 28, 2023

Regenxbio (RGNX) delivered earnings and revenue surprises of 6.76% and 12.21%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

RGNX : 16.05 (-0.86%)
CLSD : 1.2900 (-3.73%)
Blueprint Medicines (BPMC) Reports Q4 Loss, Tops Revenue Estimates Zacks - Thu Feb 16, 2023

Blueprint Medicines (BPMC) delivered earnings and revenue surprises of 2.93% and 18.58%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

BPMC : 93.10 (+0.11%)
CLSD : 1.2900 (-3.73%)
Clearside Biomedical, Inc. (CLSD) Reports Q3 Loss, Lags Revenue Estimates Zacks - Wed Nov 9, 2022

Clearside Biomedical, Inc. (CLSD) delivered earnings and revenue surprises of -425% and 98.39%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the...

CLSD : 1.2900 (-3.73%)
EVGN : 0.6502 (+4.02%)
AnaptysBio, Inc. (ANAB) Reports Q3 Loss, Misses Revenue Estimates Zacks - Tue Nov 8, 2022

AnaptysBio, Inc. (ANAB) delivered earnings and revenue surprises of -151.06% and 92.55%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

ANAB : 21.30 (+1.43%)
CLSD : 1.2900 (-3.73%)
Wave Life Sciences (WVE) Soars 13.8%: Is Further Upside Left in the Stock? Zacks - Mon Oct 17, 2022

Wave Life Sciences (WVE) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase...

WVE : 4.85 (+4.08%)
CLSD : 1.2900 (-3.73%)

Barchart Exclusives

GE Healthcare vs. GE Aerospace: Which Blue-Chip Spinoff Stock Is a Better Buy? Barchart - 1 hour ago
General Electric spinoff stocks GE HealthCare and GE Aerospace have outperformed the broader market in 2024, and bullish analysts predict up to 25% upside potential for both. But which of these two blue-chip stocks is a better buy? Let's find out. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot